Change in the Clinical Picture of Hospitalized Patients with COVID-19 between the Early and Late Period of Dominance of the Omicron SARS-CoV-2 Variant

被引:11
|
作者
Flisiak, Robert [1 ]
Zarebska-Michaluk, Dorota [2 ]
Dobrowolska, Krystyna [3 ]
Rorat, Marta [4 ,5 ]
Rogalska, Magdalena [1 ]
Krynska, Justyna Anna [1 ]
Moniuszko-Malinowska, Anna [6 ]
Czupryna, Piotr [6 ]
Kozielewicz, Dorota [7 ]
Jaroszewicz, Jerzy [8 ]
Sikorska, Katarzyna [9 ]
Bednarska, Agnieszka [10 ]
Piekarska, Anna [11 ]
Rzymski, Piotr [12 ]
机构
[1] Med Univ Bialystok, Dept Infect Dis & Hepatol, PL-15540 Bialystok, Poland
[2] Jan Kochanowski Univ, Dept Infect Dis & Allergol, PL-25317 Kielce, Poland
[3] Jan Kochanowski Univ, Coll Medicum, PL-25317 Kielce, Poland
[4] Wroclaw Med Univ, Dept Infect Dis & Hepatol, PL-51149 Wroclaw, Poland
[5] Wroclaw Med Univ, Dept Forens Med, PL-50367 Wroclaw, Poland
[6] Med Univ Bialystok, Dept Infect Dis & Neuroinfect, PL-15809 Bialystok, Poland
[7] Nicolaus Copernicus Univ, Fac Med, Dept Infect Dis & Hepatol, Coll Medicum Bydgoszcz, PL-87100 Torun, Poland
[8] Med Univ Silesia, Dept Infect Dis & Hepatol, PL-41902 Bytom, Poland
[9] Med Univ Gdansk, Fac Hlth Sci, Div Trop & Parasit Dis, PL-80210 Gdansk, Poland
[10] Med Univ Warsaw, Dept Adults Infect Dis, Hosp Infect Dis, PL-02091 Warsaw, Poland
[11] Med Univ Lodz, Dept Infect Dis & Hepatol, PL-90419 Lodz, Poland
[12] Poznan Univ Med Sci, Dept Environm Med, PL-60806 Poznan, Poland
关键词
SARS-CoV-2; COVID-19; Omicron; mortality; severity; INFECTION RECOMMENDATIONS; POLISH ASSOCIATION; EPIDEMIOLOGISTS; MANAGEMENT; OUTCOMES; WAVES;
D O I
10.3390/jcm12175572
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study aimed to compare the clinical picture of COVID-19 in the initial and later period of Omicron dominance and to identify populations still at risk. A retrospective comparison of the clinical data of 965 patients hospitalized during the early period of Omicron's dominance (EO, January-June 2022) with 897 patients from a later period (LO, July 2022-April 2023) from the SARSTer database was performed. Patients hospitalized during LO, compared to EO, were older, had a better clinical condition on admission, had a lower need for oxygen and mechanical ventilation, had less frequent lung involvement in imaging, and showed much faster clinical improvement. Moreover, the overall mortality during EO was 14%, higher than that in LO-9%. Despite the milder course of the disease, mortality exceeding 15% was similar in both groups among patients with lung involvement. The accumulation of risk factors such as an age of 60+, comorbidities, lung involvement, and oxygen saturation <90% resulted in a constant need for oxygen in 98% of patients, an 8% risk of mechanical ventilation, and a 30% mortality rate in the LO period. Multiple logistic regression revealed lower odds of death during the LO phase. Despite the milder course of infections caused by the currently dominant subvariants, COVID-19 prophylaxis is necessary in people over 60 years of age, especially those with comorbidities, and in the case of pneumonia and respiratory failure.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2
    Zhang, Jianguo
    Chen, Nan
    Zhao, Daguo
    Zhang, Jinhui
    Hu, Zhenkui
    Tao, Zhimin
    FRONTIERS IN MEDICINE, 2022, 9
  • [2] Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2
    Zhang, Jianguo
    Zhao, Daguo
    Hu, Jianhui
    Huang, Xing
    Gu, Qingqing
    Tao, Zhimin
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [3] Value of Laboratory Indicators in Predicting Pneumonia in Symptomatic COVID-19 Patients Infected with the SARS-CoV-2 Omicron Variant
    Zhu, Kongbo
    Ma, Shaolei
    Chen, Hui
    Xie, Jianfeng
    Huang, Dan
    Fu, Cuiping
    Ma, Genshan
    Huang, Yingzi
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 1159 - 1170
  • [4] Post COVID-19 condition of the Omicron variant of SARS-CoV-2
    Morioka, S.
    Tsuzuki, S.
    Suzuki, M.
    Terada, M.
    Akashi, M.
    Osanai, Y.
    Kuge, C.
    Sanada, M.
    Tanaka, K.
    Maruki, T.
    Takahashi, K.
    Saito, S.
    Hayakawa, K.
    Teruya, K.
    Hojo, M.
    Ohmagari, N.
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (11) : 1546 - 1551
  • [5] Clinical courses and outcomes of COVID-19 associated pulmonary aspergillosis in 168 patients with the SARS-CoV-2 omicron variant
    Yixuan Wang
    Yan Yao
    Qingfeng Zhang
    Hao Chen
    Yang He
    Ke Hu
    BMC Infectious Diseases, 24
  • [6] Dynamic variations in COVID-19 with the SARS-CoV-2 Omicron variant in Kazakhstan and Pakistan
    Qianqian Cui
    Zhengli Shi
    Duman Yimamaidi
    Ben Hu
    Zhuo Zhang
    Muhammad Saqib
    Ali Zohaib
    Baikadamova Gulnara
    Mukhanbetkaliyev Yersyn
    Zengyun Hu
    Shizhu Li
    Infectious Diseases of Poverty, 12
  • [7] SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with COVID-19
    Afshar, Zeinab Mohseni
    Pirzaman, Ali Tavakoli
    Karim, Bardia
    Anaraki, Shiva Rahimipour
    Hosseinzadeh, Rezvan
    Pireivatlou, Elaheh Sanjari
    Babazadeh, Arefeh
    Hosseinzadeh, Dariush
    Miri, Seyed Rouhollah
    Sio, Terence T.
    Sullman, Mark J. M.
    Barary, Mohammad
    Ebrahimpour, Soheil
    DIAGNOSTICS, 2023, 13 (03)
  • [8] Clinical courses and outcomes of COVID-19 associated pulmonary aspergillosis in 168 patients with the SARS-CoV-2 omicron variant
    Wang, Yixuan
    Yao, Yan
    Zhang, Qingfeng
    Chen, Hao
    He, Yang
    Hu, Ke
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [9] Dynamic variations in COVID-19 with the SARS-CoV-2 Omicron variant in Kazakhstan and Pakistan
    Cui, Qianqian
    Shi, Zhengli
    Yimamaidi, Duman
    Hu, Ben
    Zhang, Zhuo
    Saqib, Muhammad
    Zohaib, Ali
    Gulnara, Baikadamova
    Yersyn, Mukhanbetkaliyev
    Hu, Zengyun
    Li, Shizhu
    INFECTIOUS DISEASES OF POVERTY, 2023, 12 (01)
  • [10] COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a at the end of the tunnel?
    Mattiuzzi, Camilla
    Henry, Brandon M.
    Lippi, Giuseppe
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 118 : 167 - 168